VIA
CGON icon

Virtus Investment Advisers’s CG Oncology CGON Stock Holding History

Virtus Investment Advisers’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390K Sell
5,493
-1,167
-18% -$76.3K 0.09% 290
2026
Q1 		$451K Buy
6,660
+163
+3% +$9.23K 0.12% 229
2025
Q4 		$270K Buy
6,497
+2,203
+51% +$91.2K 0.07% 294
2025
Q3 		$173K Buy
4,294
+746
+21% +$21.7K 0.05% 321
2025
Q2 		$92.2K Sell
3,548
-2,138
-38% -$51.5K 0.03% 365
2025
Q1 		$139K Buy
+5,686
New +$160K 0.04% 356

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtus Investment Advisers's CGON Position: Q2 2026 in Review

Virtus Investment Advisers reduced its CG Oncology (CGON) stake by 18% in Q2 2026, selling an estimated $76.3K and leaving 5,493 shares worth $390K. The position accounts for 0.09% of the portfolio, ranked #290.

Virtus Investment Advisers first reported a position in CGON in Q1 2025 and has held it in 6 quarters since. The position peaked at $451K in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Virtus Investment Advisers held 5,493 shares of CG Oncology worth $390K as of Q2 2026.
  • Virtus Investment Advisers sold 1,167 CG Oncology shares in Q2 2026, an estimated $76.3K.
  • CG Oncology made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #290 holding.
  • Virtus Investment Advisers first reported a position in CG Oncology in Q1 2025 and has held it in 6 quarters since.
  • Virtus Investment Advisers's CG Oncology position peaked at $451K in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.